| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/21/2013 | US8445234 Methods of making VEGF-D polypeptides |
| 05/21/2013 | US8445233 PGC-1β, a novel PGC-1 homologue and uses therefor |
| 05/21/2013 | US8445014 Ion binding compositions |
| 05/21/2013 | US8444994 Multivalent antihelminthic vaccine |
| 05/21/2013 | US8444988 Cancer treatment method |
| 05/21/2013 | US8444957 Methods of screening for neoplastic disease states |
| 05/21/2013 | CA2528649C Analgesic and anti-inflammatory patch |
| 05/21/2013 | CA2518541C Gonadal function improving agents |
| 05/21/2013 | CA2460092C A method of diagnosis and treatment and agents useful for same |
| 05/21/2013 | CA2454147C Inhibitor of dna methylation |
| 05/21/2013 | CA2436666C Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/21/2013 | CA2428753C Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/21/2013 | CA2412436C Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/21/2013 | CA2360146C Methods for inhibiting brain tumor growth by using selected integrin antagonists |
| 05/21/2013 | CA2305385C Human toll homologues |
| 05/16/2013 | WO2013071106A1 Administration of a bis(thiohydrazide amide) compound for treating cancers |
| 05/16/2013 | WO2013070617A1 Compositions, dosage forms, and coadministration of an opioid agonist compound and an analgesic compound |
| 05/16/2013 | WO2013070606A1 Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor |
| 05/16/2013 | WO2013070586A1 Small molecule modulators of prb inactivation |
| 05/16/2013 | WO2013068876A1 Methods and compositions for treating ocular allergy |
| 05/16/2013 | US20130125259 Rna interference mediating small rna molecules |
| 05/16/2013 | US20130123366 Therapeutic Agents for the Treatment of Lymphoid Malignancies |
| 05/16/2013 | US20130123352 Xanthanodien for the treatment of cancer |
| 05/16/2013 | US20130123336 Polyplexes of Hydrophobically-Modified siRNA for Delivery of siRNA |
| 05/16/2013 | US20130123329 Microrna compositions and methods |
| 05/16/2013 | US20130123328 Methods and compositions for treating cancer |
| 05/16/2013 | US20130123327 Combined use of prame inhibitors and hdac inhibitors |
| 05/16/2013 | US20130123317 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1 |
| 05/16/2013 | US20130123311 Modulators of pharmacokinetic properties of therapeutics |
| 05/16/2013 | US20130123306 Inhibition of Mitogen-activated Protein Kinases in Cardiovascular Disease |
| 05/16/2013 | US20130123295 Treatment of neuropathic pain with n-methyl-d-aspartate (nmda) receptor antagonists |
| 05/16/2013 | US20130123270 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists |
| 05/16/2013 | US20130123269 Novel heterocycle compounds and uses thereof |
| 05/16/2013 | US20130123266 Treatment of a pathology linked to an excessive effect of tnf with a benzene sulphonamide compound |
| 05/16/2013 | US20130123265 Compounds that modulate intracellular calcium |
| 05/16/2013 | US20130123252 2,3,5-Trisubstituted Thiophene Compounds and Uses Thereof |
| 05/16/2013 | US20130123248 Pharmacological modulation of positive ampa receptor modulator effects on neurotrophin expression |
| 05/16/2013 | US20130123246 Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| 05/16/2013 | US20130123244 Hetero-Bicyclic Derivatives as HCV Inhibitors |
| 05/16/2013 | US20130123242 Compounds and methods for the treatment or prevention of flavivirus infections |
| 05/16/2013 | US20130123230 2-Thiopyrimidinones |
| 05/16/2013 | US20130123229 CB1 Receptor Antagonists and Uses Thereof |
| 05/16/2013 | US20130123217 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits |
| 05/16/2013 | US20130123214 Use of delta tocopherol for the treatment of lysosomal storage disorders |
| 05/16/2013 | US20130123189 Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate |
| 05/16/2013 | US20130123172 Treatment of Type 2 Diabetes With FTY720 |
| 05/16/2013 | US20130122295 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 05/16/2013 | US20130122122 Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased |
| 05/16/2013 | US20130122082 Methods And Compositions For The Treatment And Prevention Of Aging-Associated Conditions |
| 05/16/2013 | US20130122075 Encapsulated transfer factor compositions and methods of use |
| 05/16/2013 | US20130122064 Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration |
| 05/16/2013 | US20130122060 Using bucky paper as a therapeutic aid in medical applications |
| 05/16/2013 | US20130122024 New binder-drug conjugates (adcs) and use thereof |
| 05/16/2013 | US20130122008 Anti-IL 1- ß Antibody Combination Therapy |
| 05/16/2013 | US20130121997 Binding agents |
| 05/16/2013 | US20130121995 Compositions and Methods for Increasing Bone Mineralization |
| 05/16/2013 | US20130121993 Compositions and Methods for Treating and Diagnosing Cancer |
| 05/16/2013 | US20130121974 Methods of making enhanced, autologous fat grafts |
| 05/16/2013 | US20130121965 Treatment of hepatitis c virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent |
| 05/16/2013 | US20130121963 N-phenyl-2-pyrimidineamine derivatives |
| 05/16/2013 | US20130121960 Constitutive expression of costimulatory ligands on adoptively transferred t lymphocytes |
| 05/16/2013 | US20130121957 Hepatitis C Virus Inhibitors |
| 05/16/2013 | US20130121923 Treatment of Male Sexual Dysfunction |
| 05/16/2013 | US20130121913 Anti-CD19 Antibodies |
| 05/16/2013 | US20130121912 Microrna-198 as a tumor suppressor in pancreatic cancer |
| 05/16/2013 | CA2854879A1 Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor |
| 05/16/2013 | CA2854512A1 Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound |
| 05/16/2013 | CA2854186A1 Administration of a bis(thiohydrazide amide) compound for treating cancers |
| 05/15/2013 | EP2592081A1 Tetrahydrocarboline derivative |
| 05/15/2013 | EP2591806A1 Medicinal composition |
| 05/15/2013 | EP2591805A1 Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target EGFR family members |
| 05/15/2013 | EP2591796A1 Combination medicament comprising IL-12 and an anti-CTLA-4 ligand for tumor therapy |
| 05/15/2013 | EP2591786A1 Immunomodulating compositions and uses therefor |
| 05/15/2013 | EP2591783A1 Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |
| 05/15/2013 | EP2591775A1 Combinations comprising mtor inhibitors for treating cancer |
| 05/15/2013 | EP2590978A2 Carbapenem antibacterials with gram-negative activity |
| 05/15/2013 | EP2590654A1 Combinations of kinase inhibitors for the treatment of cancer |
| 05/15/2013 | EP2590643A2 Multi-component pharmaceuticals for treating diabetes |
| 05/15/2013 | EP2590640A1 Use of fts and analogs to treat non-autoimmune-allergic and non-allergic inflammatory conditions |
| 05/15/2013 | EP2590639A1 Treatment of delayed cutaneous hypersensitivity conditions with s-farnesylthiosalicylic acid and analogs thereof |
| 05/15/2013 | EP2590636A1 Novel gastro- retentive dosage forms comprising a gaba analog and an opioid |
| 05/15/2013 | EP2127652B1 Method for treating cancer using anticancer agent in combination |
| 05/15/2013 | CN103108631A Pharmaceutical combination for the treatment of pain |
| 05/15/2013 | CN103100085A Pharmaceutical composition |
| 05/15/2013 | CN103099786A Preparation method of micro/nanofiber sustained release preparation |
| 05/15/2013 | CN103099782A Core-shell type nano medical granule, preparation method and application thereof |
| 05/15/2013 | CN102089007B Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway |
| 05/15/2013 | CN101641103B Use of chitosans in preparing medicine for the treatment of nail inflammatory diseases |
| 05/14/2013 | US8440678 Pharmaceutical composition |
| 05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
| 05/14/2013 | US8440402 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy |
| 05/14/2013 | US8440226 Solvent/polymer solutions as suspension vehicles |
| 05/14/2013 | US8440220 Sustained release of drug antagonist; analgesic reservoir, barrier layer |
| 05/14/2013 | US8440216 Sustained release intraocular implants and related methods |
| 05/14/2013 | US8440194 Angiogenesis inhibitors; immunomodulators; side effect reduction |
| 05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/14/2013 | CA2655959C Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 05/14/2013 | CA2609972C Method and compositions for treatment of chronic neuropathic pain |
| 05/14/2013 | CA2560927C Insulin resistance-improving agent |
| 05/14/2013 | CA2549114C Immunostimulant composition comprising at least one toll-like 7 receptor or toll-like 8 receptor agonist and a toll-like 4 receptor agonist |